226 related articles for article (PubMed ID: 32235846)
1. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Kawagoe K; Wada M; Idichi T; Okada R; Yamada Y; Moriya S; Okubo K; Matsushita D; Arigami T; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Aug; 65(8):647-656. PubMed ID: 32235846
[TBL] [Abstract][Full Text] [Related]
2. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
3. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
4. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of
Wu G; Ju X; Wang Y; Li Z; Gan X
Cell Cycle; 2019 Aug; 18(16):1849-1867. PubMed ID: 31258024
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.
Sakamoto N; Naito Y; Oue N; Sentani K; Uraoka N; Oo HZ; Yanagihara K; Aoyagi K; Sasaki H; Yasui W
Cancer Sci; 2014 Feb; 105(2):236-43. PubMed ID: 24283384
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
[TBL] [Abstract][Full Text] [Related]
9. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.
Tian S; Peng P; Li J; Deng H; Zhan N; Zeng Z; Dong W
Aging (Albany NY); 2020 Feb; 12(4):3574-3593. PubMed ID: 32091407
[TBL] [Abstract][Full Text] [Related]
10. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
Kamikawaji K; Seki N; Watanabe M; Mataki H; Kumamoto T; Takagi K; Mizuno K; Inoue H
J Hum Genet; 2016 Dec; 61(12):985-993. PubMed ID: 27488440
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.
Zhang B; Yin Y; Hu Y; Zhang J; Bian Z; Song M; Hua D; Huang Z
Med Oncol; 2015 Jan; 32(1):331. PubMed ID: 25429829
[TBL] [Abstract][Full Text] [Related]
13. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
15. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
16. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
17. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.
Meng L; Chen Z; Jiang Z; Huang T; Hu J; Luo P; Zhang H; Huang M; Huang L; Chen Y; Lu M; Xu AM; Ying S
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):49-57. PubMed ID: 31828293
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
